Rep. Lisa C. McClain Sells Off Shares of Option Care Health, Inc. (NASDAQ:OPCH)

Posted by Lauren Steadman on Nov 25th, 2025

Representative Lisa C. McClain (R-Michigan) recently sold shares of Option Care Health, Inc. (NASDAQ:OPCH). In a filing disclosed on November 21st, the Representative disclosed that they had sold between $1,001 and $15,000 in Option Care Health stock on October 31st. The trade occurred in the Representative’s “CHARLES SCHWAB 401K > SCHWAB 893” account.

Representative Lisa C. McClain also recently made the following trade(s):

Sold $1,001 – $15,000 in shares of Ciena (NYSE:CIEN) on 10/31/2025.
Sold $1,001 – $15,000 in shares of Alibaba Group (NYSE:BABA) on 10/31/2025.
Sold $1,001 – $15,000 in shares of Coherent (NYSE:COHR) on 10/31/2025.
Sold $1,001 – $15,000 in shares of Clorox (NYSE:CLX) on 10/31/2025.
Sold $1,001 – $15,000 in shares of Northern Trust (NASDAQ:NTRS) on 10/31/2025.
Sold $1,001 – $15,000 in shares of Honda Motor (NYSE:HMC) on 10/31/2025.
Sold $1,001 – $15,000 in shares of Home BancShares (NYSE:HOMB) on 10/31/2025.
Sold $1,001 – $15,000 in shares of Five Below (NASDAQ:FIVE) on 10/31/2025.
Sold $1,001 – $15,000 in shares of Pure Storage (NYSE:PSTG) on 10/31/2025.
Sold $1,001 – $15,000 in shares of BHP Group (NYSE:BHP) on 10/31/2025.

Option Care Health Stock Performance

NASDAQ OPCH opened at $29.92 on Tuesday. The company has a market capitalization of $4.75 billion, a PE ratio of 23.94, a price-to-earnings-growth ratio of 1.74 and a beta of 0.88. The company has a debt-to-equity ratio of 0.81, a quick ratio of 1.00 and a current ratio of 1.52. Option Care Health, Inc. has a 52-week low of $22.29 and a 52-week high of $35.53. The company has a 50-day simple moving average of $27.74 and a 200 day simple moving average of $29.41.

Insider Transactions at Option Care Health

In other Option Care Health news, Director Norman L. Wright acquired 3,411 shares of the business’s stock in a transaction dated Tuesday, September 9th. The shares were purchased at an average cost of $29.31 per share, for a total transaction of $99,976.41. Following the transaction, the director owned 15,501 shares in the company, valued at $454,334.31. This represents a 28.21% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Harry M. Jansen Kraemer, Jr. bought 38,000 shares of the firm’s stock in a transaction that occurred on Monday, November 3rd. The shares were acquired at an average price of $25.98 per share, with a total value of $987,240.00. Following the acquisition, the director owned 413,390 shares of the company’s stock, valued at $10,739,872.20. This represents a 10.12% increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. 0.64% of the stock is owned by insiders.

Analyst Upgrades and Downgrades

OPCH has been the subject of a number of analyst reports. Citigroup restated an “outperform” rating on shares of Option Care Health in a research report on Friday, October 31st. Barrington Research reiterated an “outperform” rating and issued a $38.00 target price on shares of Option Care Health in a research note on Friday, October 31st. Cowen initiated coverage on shares of Option Care Health in a report on Thursday, October 2nd. They issued a “hold” rating for the company. Morgan Stanley initiated coverage on shares of Option Care Health in a report on Friday, October 17th. They issued an “overweight” rating and a $35.00 price target on the stock. Finally, TD Cowen lowered their price objective on Option Care Health from $30.00 to $27.00 and set a “hold” rating on the stock in a research report on Monday, November 3rd. Nine investment analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $35.67.

Get Our Latest Stock Report on Option Care Health

Institutional Inflows and Outflows

A number of institutional investors have recently added to or reduced their stakes in the company. Teton Advisors Inc. increased its stake in shares of Option Care Health by 2.2% in the second quarter. Teton Advisors Inc. now owns 17,368 shares of the company’s stock worth $564,000 after buying an additional 368 shares during the period. US Bancorp DE increased its position in shares of Option Care Health by 5.0% in the first quarter. US Bancorp DE now owns 8,199 shares of the company’s stock valued at $287,000 after acquiring an additional 393 shares during the period. Assetmark Inc. raised its stake in shares of Option Care Health by 1.6% during the second quarter. Assetmark Inc. now owns 26,690 shares of the company’s stock valued at $867,000 after acquiring an additional 416 shares during the last quarter. State of Wyoming raised its stake in shares of Option Care Health by 1.8% during the second quarter. State of Wyoming now owns 25,135 shares of the company’s stock valued at $816,000 after acquiring an additional 436 shares during the last quarter. Finally, Sheets Smith Wealth Management boosted its holdings in shares of Option Care Health by 1.9% during the second quarter. Sheets Smith Wealth Management now owns 24,938 shares of the company’s stock worth $810,000 after purchasing an additional 457 shares during the period. Institutional investors own 98.05% of the company’s stock.

About Representative McClain

Lisa McClain (Republican Party) is a member of the U.S. House, representing Michigan’s 9th Congressional District. She assumed office on January 3, 2023. Her current term ends on January 3, 2027.

McClain (Republican Party) is running for re-election to the U.S. House to represent Michigan’s 9th Congressional District. She declared candidacy for the 2026 election.

Lisa McClain lives in Romeo, Michigan. McClain earned a bachelor’s degree in business administration from Northwood University. Her career experience includes founding and working as the president of North End Support Team.

About Option Care Health

(Get Free Report)

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.